Siemens Atellica CH Total Protein II Recalled for Reagent Carryover
Siemens Healthcare Diagnostics is recalling Atellica CH Total Protein II due to reagent carryover affecting magnesium test accuracy. The recall covers all lots (13,071 units) distributed nationwide and internationally.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II medical device recall with no reported illnesses or injuries. The hazard is a technical quality issue (reagent carryover affecting test accuracy) being addressed through a precautionary recall.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the Atellica CH Total Protein II diagnostic reagent due to reagent carryover that impacts magnesium test results. Carryover from other assays performed on the Atellica CH Analyzer—including LDL Cholesterol Direct, Total Protein II, Triglycerides, and Triglycerides_2—can contaminate samples and affect magnesium result accuracy.
Approximately 13,071 units are affected by this recall, distributed nationwide and in multiple countries worldwide. The Atellica CH Total Protein II is an in vitro diagnostic used in clinical laboratory settings to quantify total protein in human serum and plasma samples.
Laboratory professionals and healthcare facility administrators should contact Siemens Healthcare Diagnostics for recall guidance. The affected reagents are identified by UDI 00630414596372, which covers all lot numbers. Users should follow the manufacturer's instructions regarding this recall.
This FDA Class II recall has been issued to address the identified quality control issue that could compromise diagnostic accuracy if not corrected.
The recalled product
- Product
- Atellica CH Total Protein II- In vitro diagnostic use in the quantitative determination of total protein in human serum and plasma (lithium heparin) using the Atellica CH Analyzer. SMN: 11097604
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Hazard
- reagent-carryover
- inaccurate-results
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI: 00630414596372 All Lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03